$SCHL

Scholastic (SCHL) offers up to $200M to buy shares at $36–$40

Scholastic Corporation has announced an amendment to its tender offer to repurchase up to $200 million of its common stock at a price range of $36.00 to $40.00 per share. The amendment clarifies and tightens certain conditions for the offer, including provisions related to legal actions, war or terrorism events occurring on or after March 20, 2026, and material adverse changes. The company reiterates its discretion to postpone, amend, or terminate the offer under specific circumstances, aligning with Exchange Act Rule 13e-4(f)(5).

Original reporting
Published Mar 31, 2026, 3:10 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Mar 31, 2026, 3:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$SCHL
Neutral
medium confidence
Mentioned
$SCHL
alphai data visualization · based on Stock Titan
Decision brief

The 30-second read

$SCHLNeutralLow
01

Why it matters

The event is unlikely to cause significant stock price swings but may provide short-term support or stabilization.

02

Market read

Limited immediate trading impact; primarily of interest to investors monitoring Scholastic's corporate actions.

03

What to watch

Market conditions, overall sector performance, and broader economic indicators could influence the stock's response beyond the tender offer specifics.

Timing: short-term (within 1–2 weeks)

Background

Scholastic's amendment to its tender offer clarifies certain conditions and emphasizes management's discretion, which is a standard corporate practice.

Company-level read

Ticker impact

$SCHLNeutralMedium confidence
Context

Primary focus due to the company's tender offer.

Expected impact

Potential short-term price stabilization or slight increase within the $36–$40 range; limited long-term impact without additional positive catalysts.

Evidence & confidence

The tender offer is a common corporate action that may support the stock price but is unlikely to cause significant volatility without broader market or company-specific developments.

Market effects

Possible positive sentiment in the educational publishing sector; limited broader industry impact.

Minimal regional effects; primarily relevant to US markets where Scholastic operates.

Negligible; company-specific event with limited global market influence.

Counterpoint

Some investors might interpret the tender offer as a sign that the company perceives its stock as undervalued, potentially leading to upward price movement.

Key entities

  • Scholastic Corporation

    A global children's publishing, education, and media company.

Related articles

$SCHLMed

Scholastic Corporation Q4 2026 Earnings Call Summary

Scholastic (Scholastic Corporation) reported a 32% rise in adjusted operating income attributed to a multiyear efficiency and integrated publishing and school growth transformation. Management said Book Fairs growth was driven by higher fair counts and digital tools. Fiscal 2027 guidance calls for 2% to 4% revenue growth and higher adjusted EBITDA, with capital returns supported by sale-leasebacks and leverage targets of 2x to 2.5x.

$SCHLMed

SCHOLASTIC CORP (SCHL): Results of Operations and Financial Condition

SCHOLASTIC CORP (SCHL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 fy26q4pressrelease.htm EX-99.1 Document Scholastic Reports Fourth Quarter and Fiscal 2026 Results Fiscal 2026 Operating Income of $15.2 Million; Adjusted EBITDA of $151.5 Million, Up 4%, in Line With Guidance Returned Over $285 Million to Shareholders During Fiscal Year

$MSFTHigh

Prediction: Microsoft Could Be the Next $5 Trillion Stock

Microsoft (MSFT) received a BUY rating and $600 price target from 24/7 Wall St., citing 43% Azure growth and a $678B commercial RPO backlog. The stock is up 27.81% over the past month and 3.29% year-to-date, with Q4 FY26 revenue of $90.01B and non-GAAP EPS of $4.74. The target implies 18.9% upside, potentially pushing market cap to $5T. Bulls highlight demand outpacing supply, while bears note capital intensity and declining PC revenue.

$LLYMedAI 9/10

FRI AM News: WisBusiness: the Podcast with Serafino Fabiano, Eli Lilly and Company; State joins lawsuit targeting Trump administration over family planning funding

Eli Lilly and Company's Kenosha facility, acquired in 2024, is part of a $4 billion investment in Wisconsin for injectable medicine production. The site, which received FDA approval in 18 months, is producing drugs like Zepbound and Mounjaro. The facility is expected to support 750 jobs and has attracted attention due to its strategic location and skilled workforce. Wisconsin has also joined a lawsuit against the Trump administration's family planning funding rules. The state collected $450.8 mi